Showing results (511-520 of 1,081) with videos related to

Sort By:
Pageof 109
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1997
Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDSC Mussini, N Mongiardo, G Manicardi, et al.
Neuromuscular Disorders : NMD|June 7, 2008
Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?Dalia Dimitri, Odile Dubourg, Thierry Maisonobe, et al.
Open Forum Infectious Diseases|May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA CohortAlessandra Vergori, Adriana Cervo, Ashley Roen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive PatientsAntonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Rheumatology (Oxford, England)|August 14, 2020
Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil countMathieu Lacou, Maxime Leroy, Nowenn Le Lan, et al.
AIDS (London, England)|November 7, 2015
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?Inma Jarrin, Nikos Pantazis, Judith Dalmau, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohortAlessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
AIDS (London, England)|September 16, 2015
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severityGiovanni Guaraldi, Thomas D Brothers, Stefano Zona, et al.
AIDS and Behavior|May 22, 2025
Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal ToxicityMarianna Menozzi, Maria Daria Di Trapani, Giulia Jole Burastero, et al.
HIV Clinical Trials|March 2, 2018
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA CohortAntonella d'Arminio Monforte, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Pageof 109